1 results match your criteria: "Barbra Streisand Women's Heart Center Cedars-Sinai Smidt Heart Institute Los Angeles CA USA.[Affiliation]"
Article Synopsis
- Obesity is a significant public health issue, impacting nearly half of U.S. adults, and is linked to increased risks of cardiovascular disease (CVD) and related mortality, prompting guidelines to recommend weight loss for prevention.
- Recent advancements in pharmacologic treatments for weight management may help healthcare professionals see obesity as a treatable chronic condition and encourage patients to pursue weight loss again after unsuccessful prior attempts.
- The article highlights the challenges and advantages of various obesity treatments and emphasizes the effectiveness and safety of new glucagon-like peptide-1 receptor agonists, suggesting these medications be prioritized in managing obesity and reducing CVD risk, especially for individuals with type 2 diabetes.